Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelets and restenosis.

B Chandrasekar1, J F Tanguay

  • 1Division of Interventional Cardiology, Montreal Heart Institute, Montreal, Canada.

Journal of the American College of Cardiology
|March 15, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hearing outcomes in children with single sided deafness: Our experience at a tertiary paediatric otorhinolaryngology unit.

International journal of pediatric otorhinolaryngology·2023
Same author

Reversion inducing cysteine rich protein with Kazal motifs and cardiovascular diseases: The RECKlessness of adverse remodeling.

Cellular signalling·2021
Same author

Sternal neoangiogenesis following internal mammary artery devascularization: an experimental model.

The Journal of cardiovascular surgery·2012
Same author

Cellular signals underlying β-adrenergic receptor mediated salivary gland enlargement.

Differentiation; research in biological diversity·2011
Same author

Conscious and anesthetized non-human primate safety pharmacology models: hemodynamic sensitivity comparison.

Journal of pharmacological and toxicological methods·2008
Same author

Antiplatelet therapy following drug-eluting stent implantation: new clinical data and recommendations.

Minerva cardioangiologica·2008
Same journal

Aortic Valve Replacement in Women of Reproductive Age.

Journal of the American College of Cardiology·2026
Same journal

Sudden Death in Cardio-Kidney-Metabolic Patients: Insights From FINE-HEART.

Journal of the American College of Cardiology·2026
Same journal

Ultra-Thin Sirolimus-Eluting Versus Everolimus-Eluting Stents in Diabetic Multivessel Coronary Artery Disease Patients: The TUXEDO-2 Trial.

Journal of the American College of Cardiology·2026
Same journal

Reframing Cardiometabolic Risk and Frailty Through Sarcopenic Obesity.

Journal of the American College of Cardiology·2026
Same journal

Imaging-Derived Sarcopenic Obesity and Cardiovascular Outcomes: Insights Into Heart Failure Risk and Muscle Biology.

Journal of the American College of Cardiology·2026
Same journal

The Measure of a Leader: Lessons in Leadership From Eugene Braunwald.

Journal of the American College of Cardiology·2026
See all related articles

Platelets play a key role in restenosis after percutaneous transluminal coronary angioplasty (PTCA), a major limitation of the procedure. This review explores platelet functions in restenosis and potential drug therapies targeting these effects.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Platelet Biology

Background:

  • Restenosis remains a significant challenge following percutaneous transluminal coronary angioplasty (PTCA).
  • Key contributors to restenosis include elastic recoil, smooth muscle cell migration and proliferation, and vascular remodeling.
  • Current therapeutic options for restenosis are limited.

Purpose of the Study:

  • To review the multifaceted role of platelets in the restenotic process after PTCA.
  • To examine the efficacy of antiplatelet agents, including glycoprotein IIb/IIIa antagonists, in mitigating restenosis.
  • To discuss experimental and clinical findings on drugs targeting platelet activity in restenosis.

Main Methods:

  • Literature review of studies investigating platelet involvement in restenosis.

Related Experiment Videos

  • Analysis of research on antiplatelet therapies and their impact on target vessel revascularization.
  • Examination of experimental and human studies on drugs inhibiting platelet effects in restenosis.

    • Main Results:

    • Platelets contribute to thrombosis and abrupt closure post-PTCA, with effects extending into the restenotic phase.
    • Glycoprotein IIb/IIIa antagonists show potential in reducing target vessel revascularization, though controversies persist.
    • Several drugs have demonstrated promise in preclinical and limited clinical studies for inhibiting platelet-mediated restenosis.

    Conclusions:

    • Platelets are critically implicated in the pathogenesis of restenosis after PTCA.
    • Targeting platelet activity presents a potential therapeutic strategy for managing restenosis.
    • Further research is warranted to fully elucidate the role of platelets and optimize antiplatelet therapies for restenosis.